Skip to main content
. Author manuscript; available in PMC: 2021 Jul 5.
Published in final edited form as: Biochem Biophys Res Commun. 2020 May 18;527(4):1000–1007. doi: 10.1016/j.bbrc.2020.05.012

Figure 2. SR9009 inhibits the development of BMDCs.

Figure 2.

(A) Bone marrow cells from C57BL/6 mice were differentiated into BMDCs in the presence of vehicle (DMSO) and increasing doses of SR9009 starting at day 0. BMDCs were analyzed for the expression of MHCII and CD86 from CD11b+CD11c+ cells by flow cytometry (top). Graphs (bottom) depict all of the experiments performed with data normalized to DMSO within each individual experiment. Data represents mean ± SEM. (n=7) Student’s two-tailed t-tests were performed for statistical analysis. *p,0.05, **p<0.01, ***p<0.001, ns, not specific.